← Back to Search

Spinal Stimulation + Mobility Devices for Cerebral Palsy

N/A

Recruiting

Led By Katherine Steele, PHD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Are 4-70 years of age

Have a neurologic condition

Must not have

Have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)

Have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities

Timeline

Screening 3 weeks

Treatment Varies

Follow Up comparing first and last minute of walking on treadmill at each experimental session.

Awards & highlights

Summary

This trial will study the effects of a new combination therapy for children with cerebral palsy- spinal stimulation and mobility devices.

Who is the study for?

This trial is for children and adults aged 4-70 with cerebral palsy or other brain-related conditions who can follow simple instructions and are medically stable. It's not for those with rheumatic diseases, active cancer, implanted stimulators or drug delivery devices, recent orthopedic surgery in the legs, uncontrolled seizures, severe osteoporosis on treatment, or significant cardiovascular issues.

What is being tested?

The study tests how non-invasive spinal stimulation combined with mobility devices affects movement in people with cerebral palsy. Participants will use these techniques during lab visits to see if there's an immediate improvement in their ability to move.

What are the potential side effects?

Potential side effects may include discomfort from the spinal stimulation or using the mobility device. There might also be fatigue due to physical activity involved in the testing process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 4 and 70 years old.

Select...

I have a condition affecting my nervous system.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a rheumatic disease like rheumatoid arthritis or lupus.

Select...

I have a bone injury or condition that could affect my ability to participate in physical rehab or tests.

Select...

I have seizures that are not controlled by medication.

Select...

I am being treated for osteoporosis.

Select...

I have a serious health condition like high blood pressure over 170/100, heart or lung disease, blood clotting issues, or need blood thinners.

Select...

I do not have heart or muscle conditions that stop me from doing physical therapy.

Select...

My cancer is currently active.

Select...

I haven't had leg or brain surgery in the past year that could affect study results.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ physical exam conducted at the beginning and end of experimental session.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~physical exam conducted at the beginning and end of experimental session.

This trial's timeline: 3 weeks for screening, Varies for treatment, and physical exam conducted at the beginning and end of experimental session. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Muscle Coordination

Secondary study objectives

Modified Ashworth Scale

Plantarflexor Muscle Strength

Trial Design

1Treatment groups

Experimental Treatment

Group I: Neurologic DisordersExperimental Treatment2 Interventions

Evaluation of individual and combined effects of mobility devices and spinal stimulation for individuals with neurologic disorders.

0 / 10Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor

1,791 Previous Clinical Trials

1,905,486 Total Patients Enrolled

5 Trials studying Premature Birth

2,190 Patients Enrolled for Premature Birth

Seattle Children's HospitalOTHER

308 Previous Clinical Trials

5,228,663 Total Patients Enrolled

3 Trials studying Premature Birth

460 Patients Enrolled for Premature Birth

Katherine Steele, PHDPrincipal InvestigatorUniversity of Washington

Media Library

Mobility Device Clinical Trial Eligibility Overview. Trial Name: NCT05520359 — N/A

Premature Birth Research Study Groups: Neurologic Disorders

Premature Birth Clinical Trial 2023: Mobility Device Highlights & Side Effects. Trial Name: NCT05520359 — N/A

Mobility Device 2023 Treatment Timeline for Medical Study. Trial Name: NCT05520359 — N/A

~6 spots leftby Sep 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.